CN Stock MarketDetailed Quotes

Shaanxi Panlong Pharmaceutical Group (002864)

Watchlist
  • 30.48
  • -0.27-0.88%
Not Open May 18 15:00 CST
3.24BMarket Cap37.31P/E (TTM)

Shaanxi Panlong Pharmaceutical Group (002864) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-11.06%222.54M
17.15%1.14B
17.37%841.45M
26.06%574.02M
19.08%250.21M
-0.71%973.86M
0.10%716.92M
-8.93%455.36M
-6.87%210.12M
0.67%980.83M
Operating revenue
-11.06%222.54M
17.15%1.14B
17.37%841.45M
26.06%574.02M
19.08%250.21M
-0.71%973.86M
0.10%716.92M
-8.93%455.36M
-6.87%210.12M
0.67%980.83M
Other operating revenue
----
-22.30%1.88M
----
22.63%1.25M
----
-8.11%2.41M
----
-21.09%1.02M
----
-19.32%2.63M
Total operating cost
-11.36%189.46M
20.74%1.02B
18.29%735.24M
28.13%502.13M
19.26%213.74M
-0.37%843.76M
0.32%621.57M
-10.09%391.91M
-10.46%179.23M
-0.31%846.85M
Operating cost
-12.88%100.47M
43.92%549.08M
45.27%398.13M
64.17%280.8M
44.23%115.32M
-7.57%381.52M
-8.44%274.06M
-24.28%171.04M
-30.01%79.96M
1.16%412.75M
Operating tax surcharges
-4.71%2.68M
10.01%12.29M
4.34%8.72M
4.39%5.81M
12.71%2.81M
2.50%11.17M
13.32%8.35M
15.08%5.57M
27.89%2.49M
6.46%10.9M
Operating expense
-14.48%72.02M
-4.84%349.24M
-4.93%271.15M
-0.60%181.09M
-3.83%84.21M
1.64%367.02M
6.80%285.23M
4.10%182.18M
21.24%87.56M
-0.45%361.1M
Administration expense
-5.87%12.62M
-3.60%67.32M
-4.54%45.83M
-2.73%30.44M
5.63%13.41M
21.04%69.83M
16.83%48.01M
17.74%31.29M
4.09%12.69M
8.10%57.69M
Financial expense
73.78%-1.75M
47.26%-12.3M
29.22%-12.69M
4.62%-11.86M
7.54%-6.66M
-47.29%-23.32M
-63.29%-17.93M
-76.91%-12.43M
-93.41%-7.2M
-406.45%-15.83M
-Interest expense (Financial expense)
-30.04%506.35K
39.91%2.18M
-9.48%2.39M
-11.22%1.52M
-9.76%723.79K
-74.45%1.56M
-48.26%2.64M
-54.95%1.71M
-63.24%802.1K
-56.08%6.11M
-Interest Income (Financial expense)
69.41%-2.26M
41.67%-14.55M
26.62%-15.13M
5.44%-13.42M
7.70%-7.39M
-13.06%-24.95M
-27.34%-20.62M
-30.05%-14.19M
-34.84%-8.01M
-28.41%-22.06M
Research and development
-26.33%3.42M
41.49%53.11M
1.05%24.1M
11.18%15.85M
24.87%4.64M
85.31%37.54M
51.49%23.85M
34.24%14.26M
13.33%3.72M
11.09%20.26M
Credit Impairment Loss
23.78%-1.8M
-993.76%-24.29M
-89.85%-7.35M
-71.81%-9.17M
-13.27%-2.36M
43.07%-2.22M
0.95%-3.87M
-32.56%-5.34M
-14.81%-2.08M
12.84%-3.9M
Asset Impairment Loss
-343.31%-133.97K
26.59%-165.18K
-2,882.19%-211.24K
6.29%-187.61K
120.91%55.06K
77.32%-225K
99.16%-7.08K
42.14%-200.2K
-307.67%-263.29K
-311.35%-992.18K
Other net revenue
1,032.77%2.32M
-245.40%-12.01M
-35.75%1.73M
-96.75%-1.23M
-10.13%-248.44K
832.22%8.26M
96.44%2.69M
41.53%-623.08K
45.67%-225.58K
149.10%886.17K
Invest income
-5.43%-56.02K
-121.22%-133.89K
-1.52%-174.19K
-1.88%-119.5K
-2.56%-53.13K
140.53%630.89K
85.30%-171.59K
-11.50%-117.29K
-1,755.90%-51.81K
-1,282.11%-1.56M
-Including: Investment income associates
-5.43%-56.02K
-126.82%-133.89K
-1.52%-174.19K
-1.88%-119.5K
-2.56%-53.13K
382.51%499.2K
-10.59%-171.59K
-11.50%-117.29K
-1,755.90%-51.81K
-56.90%-176.7K
Asset deal income
64.01%-113.73
1,016.73%129.51K
3,000.66%129.68K
-8,100.60%-10.51K
---315.97
-108.40%-14.13K
59.47%-4.47K
98.84%-128.18
----
--168.16K
Other revenue
104.04%4.31M
23.36%12.45M
38.44%9.33M
64.19%8.26M
-2.90%2.11M
40.77%10.09M
-7.59%6.74M
46.99%5.03M
47.61%2.17M
137.00%7.17M
Operating profit
-2.28%35.4M
-20.41%110.12M
10.10%107.94M
12.47%70.66M
18.14%36.23M
2.60%138.37M
0.05%98.04M
-0.36%62.83M
22.45%30.66M
9.62%134.86M
Add:Non operating Income
-74.82%330
-7.42%179.18K
-98.57%73.45K
-98.93%54.6K
-99.97%1.31K
-56.16%193.54K
1,281.53%5.14M
1,995.27%5.11M
1,964.27%5.04M
-3.22%441.48K
Less:Non operating expense
24,368.32%1.81M
-16.20%1.35M
-18.45%1.3M
142.77%656.22K
-88.48%7.4K
-73.42%1.61M
123.36%1.6M
167.76%270.31K
-44.89%64.22K
40.80%6.05M
Total profit
-7.26%33.59M
-20.45%108.95M
5.05%106.71M
3.54%70.06M
1.63%36.22M
5.96%136.95M
4.03%101.58M
7.07%67.67M
41.60%35.64M
8.45%129.25M
Less:Income tax cost
134.60%11.86M
-24.06%12.93M
39.15%17.11M
22.46%10.08M
10.36%5.05M
-3.82%17.03M
-6.35%12.29M
-1.14%8.23M
36.47%4.58M
10.42%17.7M
Net profit
-30.26%21.74M
-19.93%96.02M
0.36%89.6M
0.92%59.98M
0.35%31.17M
7.51%119.92M
5.64%89.28M
8.32%59.44M
42.39%31.06M
8.14%111.55M
Net profit from continuing operation
-30.26%21.74M
-19.93%96.02M
0.36%89.6M
0.92%59.98M
0.35%31.17M
7.51%119.92M
5.64%89.28M
8.32%59.44M
42.39%31.06M
8.14%111.55M
Less:Minority Profit
69.23%-25.67K
25.67%-257.86K
29.61%-203.45K
28.53%-155.68K
6.58%-83.43K
-131.17%-346.9K
-170.25%-289.04K
-135.34%-217.82K
-135.63%-89.31K
-43.89%1.11M
Net profit of parent company owners
-30.36%21.76M
-19.95%96.28M
0.26%89.81M
0.81%60.14M
0.33%31.25M
8.91%120.27M
6.50%89.57M
9.95%59.65M
44.46%31.15M
9.16%110.43M
Earning per share
Basic earning per share
-30.00%0.21
-20.00%0.92
0.00%0.85
0.00%0.57
0.00%0.3
0.00%1.15
-6.59%0.85
-1.72%0.57
25.00%0.3
-2.54%1.15
Diluted earning per share
-30.00%0.21
-20.00%0.92
0.00%0.85
0.00%0.57
0.00%0.3
1.77%1.15
-6.59%0.85
-1.72%0.57
30.43%0.3
-3.42%1.13
Other composite income
Total composite income
-30.26%21.74M
-19.93%96.02M
0.36%89.6M
0.92%59.98M
0.35%31.17M
7.51%119.92M
5.64%89.28M
8.32%59.44M
42.39%31.06M
8.14%111.55M
Total composite income of parent company owners
-30.36%21.76M
-19.95%96.28M
0.26%89.81M
0.81%60.14M
0.33%31.25M
8.91%120.27M
6.50%89.57M
9.95%59.65M
44.46%31.15M
9.16%110.43M
Total composite income of minority owners
69.23%-25.67K
25.67%-257.86K
29.61%-203.45K
28.53%-155.68K
6.58%-83.43K
-131.17%-346.9K
-170.25%-289.04K
-135.34%-217.82K
-135.63%-89.31K
-43.89%1.11M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -11.06%222.54M17.15%1.14B17.37%841.45M26.06%574.02M19.08%250.21M-0.71%973.86M0.10%716.92M-8.93%455.36M-6.87%210.12M0.67%980.83M
Operating revenue -11.06%222.54M17.15%1.14B17.37%841.45M26.06%574.02M19.08%250.21M-0.71%973.86M0.10%716.92M-8.93%455.36M-6.87%210.12M0.67%980.83M
Other operating revenue -----22.30%1.88M----22.63%1.25M-----8.11%2.41M-----21.09%1.02M-----19.32%2.63M
Total operating cost -11.36%189.46M20.74%1.02B18.29%735.24M28.13%502.13M19.26%213.74M-0.37%843.76M0.32%621.57M-10.09%391.91M-10.46%179.23M-0.31%846.85M
Operating cost -12.88%100.47M43.92%549.08M45.27%398.13M64.17%280.8M44.23%115.32M-7.57%381.52M-8.44%274.06M-24.28%171.04M-30.01%79.96M1.16%412.75M
Operating tax surcharges -4.71%2.68M10.01%12.29M4.34%8.72M4.39%5.81M12.71%2.81M2.50%11.17M13.32%8.35M15.08%5.57M27.89%2.49M6.46%10.9M
Operating expense -14.48%72.02M-4.84%349.24M-4.93%271.15M-0.60%181.09M-3.83%84.21M1.64%367.02M6.80%285.23M4.10%182.18M21.24%87.56M-0.45%361.1M
Administration expense -5.87%12.62M-3.60%67.32M-4.54%45.83M-2.73%30.44M5.63%13.41M21.04%69.83M16.83%48.01M17.74%31.29M4.09%12.69M8.10%57.69M
Financial expense 73.78%-1.75M47.26%-12.3M29.22%-12.69M4.62%-11.86M7.54%-6.66M-47.29%-23.32M-63.29%-17.93M-76.91%-12.43M-93.41%-7.2M-406.45%-15.83M
-Interest expense (Financial expense) -30.04%506.35K39.91%2.18M-9.48%2.39M-11.22%1.52M-9.76%723.79K-74.45%1.56M-48.26%2.64M-54.95%1.71M-63.24%802.1K-56.08%6.11M
-Interest Income (Financial expense) 69.41%-2.26M41.67%-14.55M26.62%-15.13M5.44%-13.42M7.70%-7.39M-13.06%-24.95M-27.34%-20.62M-30.05%-14.19M-34.84%-8.01M-28.41%-22.06M
Research and development -26.33%3.42M41.49%53.11M1.05%24.1M11.18%15.85M24.87%4.64M85.31%37.54M51.49%23.85M34.24%14.26M13.33%3.72M11.09%20.26M
Credit Impairment Loss 23.78%-1.8M-993.76%-24.29M-89.85%-7.35M-71.81%-9.17M-13.27%-2.36M43.07%-2.22M0.95%-3.87M-32.56%-5.34M-14.81%-2.08M12.84%-3.9M
Asset Impairment Loss -343.31%-133.97K26.59%-165.18K-2,882.19%-211.24K6.29%-187.61K120.91%55.06K77.32%-225K99.16%-7.08K42.14%-200.2K-307.67%-263.29K-311.35%-992.18K
Other net revenue 1,032.77%2.32M-245.40%-12.01M-35.75%1.73M-96.75%-1.23M-10.13%-248.44K832.22%8.26M96.44%2.69M41.53%-623.08K45.67%-225.58K149.10%886.17K
Invest income -5.43%-56.02K-121.22%-133.89K-1.52%-174.19K-1.88%-119.5K-2.56%-53.13K140.53%630.89K85.30%-171.59K-11.50%-117.29K-1,755.90%-51.81K-1,282.11%-1.56M
-Including: Investment income associates -5.43%-56.02K-126.82%-133.89K-1.52%-174.19K-1.88%-119.5K-2.56%-53.13K382.51%499.2K-10.59%-171.59K-11.50%-117.29K-1,755.90%-51.81K-56.90%-176.7K
Asset deal income 64.01%-113.731,016.73%129.51K3,000.66%129.68K-8,100.60%-10.51K---315.97-108.40%-14.13K59.47%-4.47K98.84%-128.18------168.16K
Other revenue 104.04%4.31M23.36%12.45M38.44%9.33M64.19%8.26M-2.90%2.11M40.77%10.09M-7.59%6.74M46.99%5.03M47.61%2.17M137.00%7.17M
Operating profit -2.28%35.4M-20.41%110.12M10.10%107.94M12.47%70.66M18.14%36.23M2.60%138.37M0.05%98.04M-0.36%62.83M22.45%30.66M9.62%134.86M
Add:Non operating Income -74.82%330-7.42%179.18K-98.57%73.45K-98.93%54.6K-99.97%1.31K-56.16%193.54K1,281.53%5.14M1,995.27%5.11M1,964.27%5.04M-3.22%441.48K
Less:Non operating expense 24,368.32%1.81M-16.20%1.35M-18.45%1.3M142.77%656.22K-88.48%7.4K-73.42%1.61M123.36%1.6M167.76%270.31K-44.89%64.22K40.80%6.05M
Total profit -7.26%33.59M-20.45%108.95M5.05%106.71M3.54%70.06M1.63%36.22M5.96%136.95M4.03%101.58M7.07%67.67M41.60%35.64M8.45%129.25M
Less:Income tax cost 134.60%11.86M-24.06%12.93M39.15%17.11M22.46%10.08M10.36%5.05M-3.82%17.03M-6.35%12.29M-1.14%8.23M36.47%4.58M10.42%17.7M
Net profit -30.26%21.74M-19.93%96.02M0.36%89.6M0.92%59.98M0.35%31.17M7.51%119.92M5.64%89.28M8.32%59.44M42.39%31.06M8.14%111.55M
Net profit from continuing operation -30.26%21.74M-19.93%96.02M0.36%89.6M0.92%59.98M0.35%31.17M7.51%119.92M5.64%89.28M8.32%59.44M42.39%31.06M8.14%111.55M
Less:Minority Profit 69.23%-25.67K25.67%-257.86K29.61%-203.45K28.53%-155.68K6.58%-83.43K-131.17%-346.9K-170.25%-289.04K-135.34%-217.82K-135.63%-89.31K-43.89%1.11M
Net profit of parent company owners -30.36%21.76M-19.95%96.28M0.26%89.81M0.81%60.14M0.33%31.25M8.91%120.27M6.50%89.57M9.95%59.65M44.46%31.15M9.16%110.43M
Earning per share
Basic earning per share -30.00%0.21-20.00%0.920.00%0.850.00%0.570.00%0.30.00%1.15-6.59%0.85-1.72%0.5725.00%0.3-2.54%1.15
Diluted earning per share -30.00%0.21-20.00%0.920.00%0.850.00%0.570.00%0.31.77%1.15-6.59%0.85-1.72%0.5730.43%0.3-3.42%1.13
Other composite income
Total composite income -30.26%21.74M-19.93%96.02M0.36%89.6M0.92%59.98M0.35%31.17M7.51%119.92M5.64%89.28M8.32%59.44M42.39%31.06M8.14%111.55M
Total composite income of parent company owners -30.36%21.76M-19.95%96.28M0.26%89.81M0.81%60.14M0.33%31.25M8.91%120.27M6.50%89.57M9.95%59.65M44.46%31.15M9.16%110.43M
Total composite income of minority owners 69.23%-25.67K25.67%-257.86K29.61%-203.45K28.53%-155.68K6.58%-83.43K-131.17%-346.9K-170.25%-289.04K-135.34%-217.82K-135.63%-89.31K-43.89%1.11M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More